The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Rightek Co., Ltd.

9 May 2018 07:00

RNS Number : 4127N
Microsaic Systems plc
09 May 2018
 

9 May 2018

Microsaic Systems plc

 

("Microsaic"or the "Company")

 

Agreement with Rightek Co., Ltd.

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed an agreement with Rightek Co., Ltd. ("Rightek") (the "Agreement").

 

The Agreement covers the distribution of Microsaic's 4500 MiD® mass spectrometry detector via Rightek's distribution network in Taiwan.

 

Glenn Tracey, CEO of Microsaic, commented, "This agreement with Rightek further consolidates our strategy to extend the sales of our unique compact, point of need technology into the Asia Pacific area.

 

Rightek combines expertise in understanding end-user applications, together with a proven track record of working with a wide range of specialised scientific instrumentation.

 

This agreement is in line with our strategy to partner with locally based and established channel partners, with expertise in selling innovative analytical instrumentation to progressive end-users in process and pharmaceutical markets."

 

Moses Shih, General Manager of Rightek, added "Rightek is committed to helping our customers achieve success, to solve their problems by finding suitable high-quality technologies to meet ever challenging demands. We believe that Microsaic's compact, point-of-need systems can improve the efficiencies by optimizing the process in chemical and pharma industries."

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong

 

 

+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler

+44 (0)20 3934 6630

 

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.

 

 

About Rightek Co., Ltd

Established in December 2007, Rightek is headquartered in Wujin District, New Taipei City, and also has offices in Taichung and Kaohsiung. Rightek distributes a wide range of scientific equipment through its Analytical, Synthesis and Process Equipment divisions.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREASSPELEPEFF
Date   Source Headline
19th Nov 202011:42 amRNSForm 8.5 (EPT/RI)
18th Nov 202010:10 amRNSForm 8.5 (EPT/RI)
16th Nov 202010:33 amRNSForm 8.5 (EPT/RI)
12th Nov 202010:34 amRNSForm 8.5 (EPT/RI)
11th Nov 202011:38 amRNSForm 8.5 (EPT/RI)
10th Nov 202011:27 amRNSForm 8.5 (EPT/RI)
9th Nov 20209:10 amRNSForm 8.5 (EPT/RI)
5th Nov 202010:50 amRNSForm 8.5 (EPT/RI)
4th Nov 202010:48 amRNSForm 8.5 (EPT/RI)
3rd Nov 202010:48 amRNSForm 8.5 (EPT/RI)
2nd Nov 202011:38 amRNSForm 8.5 (EPT/RI)
26th Oct 202011:12 amRNSForm 8.5 (EPT/RI)
23rd Oct 20203:29 pmRNSForm 8.3 - Microsaic Systems PLC
23rd Oct 20209:01 amRNSForm 8.5 (EPT/RI)
22nd Oct 202012:08 pmRNSForm 8.5 (EPT/RI)
20th Oct 20208:46 amRNSForm 8.5 (EPT/RI)
19th Oct 20208:24 amRNSForm 8.5 (EPT/RI)
16th Oct 202010:59 amRNSForm 8.5 (EPT/RI)
15th Oct 20201:11 pmRNSForm 8.5 (EPT/RI)
14th Oct 202011:02 amRNSForm 8.5 (EPT/RI)
13th Oct 202010:32 amRNSForm 8.5 (EPT/RI)
12th Oct 202010:15 amRNSForm 8.5 (EPT/RI)
1st Oct 202012:23 pmRNSForm 8.5 (EPT/RI)
25th Sep 202011:43 amRNSForm 8.5 (EPT/RI)
24th Sep 20209:59 amRNSForm 8.5 (EPT/RI)
24th Sep 20209:30 amRNSForm 8.5 (EPT/RI)
23rd Sep 202010:48 amRNSForm 8.5 (EPT/RI)
22nd Sep 202010:52 amRNSForm 8.5 (EPT/RI)
21st Sep 202011:23 amRNSForm 8.5 (EPT/RI)
18th Sep 202011:47 amRNSForm 8.5 (EPT/RI)
17th Sep 202010:02 amRNSForm 8.5 (EPT/RI)
15th Sep 202011:38 amRNSForm 8.5 (EPT/RI)
14th Sep 202010:49 amRNSForm 8.5 (EPT/RI)
9th Sep 202011:47 amRNSForm 8.5 (EPT/RI)
7th Sep 202010:25 amRNSForm 8.5 (EPT/RI)
4th Sep 20208:25 amRNSForm 8.5 (EPT/RI)
3rd Sep 20209:24 amRNSForm 8.5 (EPT/RI)
2nd Sep 20207:00 amRNSInterim Results
1st Sep 202010:51 amRNSForm 8.5 (EPT/RI)
28th Aug 202012:06 pmRNSForm 8.5 (EPT/RI)
27th Aug 20209:04 amRNSForm 8.5 (EPT/RI)
26th Aug 20209:04 amRNSForm 8.5 (EPT/RI)
25th Aug 202011:03 amRNSForm 8.5 (EPT/RI)
19th Aug 20203:04 pmRNSForm 8.3 - Microsaic Systems PLC
18th Aug 20208:50 amRNSForm 8.5 (EPT/RI)
17th Aug 20209:30 amRNSForm 8.5 (EPT/RI)
14th Aug 202012:48 pmRNSForm 8.3 - Microsaic Systems plc
13th Aug 202011:57 amRNSForm 8.5 (EPT/RI)
12th Aug 20202:58 pmRNSForm 8.3 - Microsaic Systems PLC
12th Aug 202010:20 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.